Monday links: the cost of money
MarketsHealth care stocks are at all-time highs. (trendlabs.com)The momentum trade can unwind quickly. (wsj.com)ETFsWhat you need to know about T-bill ETFs. (advisorperspectives.com)Why niche ETF sponsors keep getting snapped up. (pionline.com)A look at the history of the Teucrium Wheat Fund ($WEAT). (philbak.substack.com)Prediction marketsKalshi has teamed up with Alpaca to push overseas. (cnbc.com)Why a prediction markets case will likely end up in the Supreme Court. (frontofficesports.com)George Santos earned a lifetime ban from Kalshi. (wired.com)Private equityPE firms are buying up companies in construction and engineering. (pitchbook.com)Why PE is investing big in the business of private jet infrastructure. (bloomberg.com)Stay in touchDon't miss a thing! Sign up for our daily e-mail newsletter. (abnormalreturns.com)Work in wealth management? Sign up for our exclusive Talking Wealth newsletter. (talkingwealthpod.com)PharmaThe FDA approved Mounjaro to lower the risk of heart ev
Markets
- Health care stocks are at all-time highs. (trendlabs.com)
- The momentum trade can unwind quickly. (wsj.com)
ETFs
- What you need to know about T-bill ETFs. (advisorperspectives.com)
- Why niche ETF sponsors keep getting snapped up. (pionline.com)
- A look at the history of the Teucrium Wheat Fund ($WEAT). (philbak.substack.com)
Prediction markets
- Kalshi has teamed up with Alpaca to push overseas. (cnbc.com)
- Why a prediction markets case will likely end up in the Supreme Court. (frontofficesports.com)
- George Santos earned a lifetime ban from Kalshi. (wired.com)
Private equity
- PE firms are buying up companies in construction and engineering. (pitchbook.com)
- Why PE is investing big in the business of private jet infrastructure. (bloomberg.com)
Stay in touch
- Don't miss a thing! Sign up for our daily e-mail newsletter. (abnormalreturns.com)
- Work in wealth management? Sign up for our exclusive Talking Wealth newsletter. (talkingwealthpod.com)
Pharma
- The FDA approved Mounjaro to lower the risk of heart events. (time.com)
- Eli Lilly ($LLY) is buying another biotech startup, Merida Biosciences. (barrons.com)
- A look at just how much Revolution Medicines ($RVMD) new pancreatic cancer drug will cost. (nytimes.com)
- A new class of baldness drugs is nearing the finish line. (bloomberg.com)
Economy
- Why grocery prices are set to go higher. (axios.com)
- Companies are saying inflation isn't going anywhere. (thetranscript.substack.com)
- How much is the Iran war costing each American? (newyorker.com)
- Electricity is the new oil. (politico.com)
Earlier on Abnormal Returns
- Adviser links: the custody shift. (abnormalreturns.com)
- What you missed in our Sunday linkfest. (abnormalreturns.com)
- Top clicks last week on Abnormal Returns. (abnormalreturns.com)
Mixed media
Share
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0